Patrick Daly Joins Terumo Blood and Cell Technologies as New Chief Business Officer

Patrick Daly Takes on the Role of Chief Business Officer at Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies (Terumo BCT), based in Lakewood, Colorado, has recently announced a key addition to its leadership team with the appointment of Patrick Daly as its Chief Business Officer. This strategic move aims to align business areas within the company and support its growth trajectory in a rapidly evolving healthcare market.

Having more than three decades of experience in the healthcare field, Patrick Daly comes to Terumo BCT from IQVIA, where he played a critical role in establishing the MedTech Global Data franchise. This role involved providing innovative technology solutions to the life sciences sector, underscoring Daly's capability in addressing the needs of a changing marketplace.

Before his tenure at IQVIA, Daly served as the President and CEO of Cohera Medical, a company devoted to advancing medical technology through innovative products. He also holds a position as an independent Board Director at BioStem Technologies, showcasing his extensive influence in the healthcare landscape. His career includes various senior leadership roles at Johnson & Johnson, where he concentrated on strategic marketing, sales, and business development across multiple regions.

Daly's academic background is equally impressive; he earned a Bachelor of Science in Foreign Area Studies from the United States Military Academy at West Point. This varied experience enhances his ability to integrate the company's offerings and drive innovative solutions across Terumo BCT's business models, as noted by Antoinette Gawin, the President and CEO of the company.